Article

Combining xQTL and genome-wide association studies from ethnically diverse populations improves druggable gene discovery

2025-05-28

Abstract excerpt

<title>Abstract</title> <p>Repurposing existing medicines to target disease-associated genes represents a promising strategy for developing new treatments for complex diseases. However, progress has been hindered by a lack of viable candidate drug targets identified through genome-wide association studies (GWAS). Gene-based association tests provide a more powerful alternative to traditional single nucleotide pol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 11e9f60a-4877-5963-9327-d81d898195bf
DOI: 10.21203/rs.3.rs-6700169/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combining xQTL and genome-wide association studies from ethnically diverse populations improves druggable gene discoveryDOI 10.21203/rs.3.rs-6700169/v1Read

Combining xQTL and genome-wide association studies from diverse populations improves druggable gene discovery.Semantic proximity Read

Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s diseaseSemantic proximity Read

omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative DiseasesSemantic proximity Read

Bayesian inference of genetic pleiotropy identifies drug targets and repurposable medicines for human complex diseasesSemantic proximity Read

Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders.Semantic proximity Read

Integration of genetic evidence to identify approved drug targetsSemantic proximity Read

Re-thinking Alzheimer's disease therapeutic targets using gene-based testsSemantic proximity Read

Genetically informed drug target prioritisation and repurposing for major depressive disorderSemantic proximity Read

Multicomponent Mendelian randomization and machine learning studies of potential drug targets for neurodegenerative diseasesSemantic proximity Read

The tissue-specific effects of glucose-lowering drug targets on aging mediated through DNA methylation: a multi-omics genetic studySemantic proximity Read

G2DR: a genotype-first framework for genetics-informed target prioritization and drug repurposing.Semantic proximity Read

Leveraging Genetic Correlations to Prioritize Drug Groups for Repurposing in Type 2 DiabetesSemantic proximity Read